EXLS Stock Charts

Quarterly

Annual

Unit: USD	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31

cash flows from operating activities:
net income	58,161,000	66,051,000	66,561,000	50,672,000	53,037,000	45,825,000	48,763,000	40,283,000	43,876,000	49,068,000	51,331,000	31,849,000	39,095,000	35,846,000	36,178,000	28,299,000	26,507,000	28,021,000	31,931,000	32,218,000	26,418,000	8,429,000	22,411,000	21,356,000	19,044,000	12,564,000	14,695,000	3,857,000	15,249,000	14,462,000	23,158,000	-9,355,000	21,077,000	20,378,000	16,788,000	15,488,000	16,050,000	16,375,000	13,820,000	14,762,000	15,162,000	12,074,000	9,567,000	7,460,000	6,075,000	7,763,000	11,147,000	15,859,000	13,240,000	9,236,000	9,762,000	12,163,000	11,703,000	9,054,000	8,916,000	9,554,000	8,390,000	8,475,000	8,361,000	8,296,000	7,804,000	4,869,000	5,623,000	7,524,000	3,994,000	1,252,000	2,883,000	3,419,045	-1,075,262	5,264,072	6,799,812	9,775,472	6,239,440	5,620,048	5,408,626	6,038,200
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization expense	15,188,000	14,147,000	13,542,000	16,153,000	13,838,000	12,893,000	12,337,000	12,270,000	11,546,000	13,056,000	13,408,000	14,109,000	14,254,000	14,070,000	13,669,000	12,497,000	12,425,000	12,468,000	12,266,000	13,264,000	12,443,000	12,334,000	12,472,000
stock-based compensation expense	23,139,000	16,392,000	19,187,000	15,479,000	21,232,000	18,095,000	17,852,000	15,452,000	17,067,000	11,511,000	14,407,000	12,616,000	12,186,000	13,340,000	11,224,000	9,825,000	10,894,000	10,070,000	7,832,000	7,385,000	8,346,000	7,726,000	4,778,000	4,532,000	7,427,000	7,155,000	6,956,000	6,590,000	5,344,000	6,893,000	5,074,000	6,270,000	5,708,000	5,107,000	5,956,000	5,027,000	4,484,000	4,450,000	5,809,000	3,767,000	4,471,000	3,554,000	4,255,000	2,493,000	2,376,000	1,966,000	4,176,000	2,360,000	2,967,000	2,860,000	3,645,000	2,087,000	1,871,000	2,715,000	2,743,000	2,175,000	2,160,000	2,879,000	2,248,000
reduction in the carrying amount of operating lease right-of-use assets	5,904,000	6,428,000	6,061,000	5,694,000	5,721,000	5,354,000	4,995,000
fair value mark-to-market of investments	-1,887,000	-1,220,000	-84,000		-932,000	-654,000	353,000
unrealized foreign currency exchange (gain)/loss	-7,664,000	-2,044,000	-1,270,000		-145,000	-2,645,000	-274,000
deferred income tax benefit	9,085,000	-7,673,000	-7,932,000	5,538,000	-8,347,000	-8,396,000	-8,680,000	-5,187,000	-8,272,000	-8,839,000	-9,444,000		-4,159,000	-1,269,000	-193,000		-2,637,000
others	394,000	139,000	1,442,000	-339,000	-271,000	-446,000	376,000	-436,000	182,000	42,000	1,160,000	-730,000	457,000	-36,000	819,000	-374,000	446,000	-72,000	216,000	393,000	269,000	-1,178,000	-26,000	-1,057,000	-1,109,000	544,000	417,000	710,000	70,000	95,000	28,000	240,000	-15,000	34,000	-7,000	-23,000	-17,000	-55,000	-12,000	-29,000	-40,000	-196,000	-13,000
change in operating assets and liabilities:
accounts receivable	-7,083,000	-3,081,000	-35,231,000	33,547,000	-8,892,000	7,570,000	-27,578,000	-2,754,000	-18,113,000	2,521,000	-30,896,000	-55,000	-21,681,000	-726,000	-45,659,000	7,187,000	-10,719,000	-22,334,000	-11,818,000	8,618,000	3,698,000	29,898,000	-17,518,000	9,382,000	3,000	-4,462,000	-12,016,000	-692,000	2,365,000	-11,129,000	-590,000	1,582,000	-12,289,000	-3,435,000	-6,340,000	-1,540,000	3,099,000	-5,131,000	-14,490,000	5,560,000	-4,634,000	-4,234,000	-5,779,000	2,422,000	-1,633,000	4,185,000	-1,713,000	-4,219,000	2,437,000	-834,000	-3,062,000	1,623,000	-3,761,000	-3,109,000	-2,839,000	3,061,000	-2,912,000	-4,207,000	-1,051,000	-2,422,000	-474,000	-5,230,000	-317,000	-3,327,000	59,000	490,000	2,491,000	10,244,916	504,570	3,054,741	-7,605,218	99,980	-5,043,135	853,260	-8,328,839	715,705
other current and non-current assets	5,082,000			-41,412,000	7,546,000
income taxes payable	-5,162,000	-7,462,000	11,664,000	-17,766,000	-3,516,000	-16,365,000	11,443,000	-6,260,000	-1,412,000	-18,493,000	7,883,000	4,736,000																																															609,000	-3,758,000	-33,000	-587,000	-1,472,000	750,000	1,908,000	-108,000	-36,000	-646,486	-845,843	202,986	-1,516,968	-373,246	1,153,177	-1,900,069	-912,045	473,917
deferred revenue	-4,410,000	1,673,000	753,000	6,967,000	-3,103,000	-2,691,000	5,829,000	-3,196,000	-3,061,000	2,929,000	2,451,000	370,000	-2,173,000	569,000	3,707,000	8,463,000	-364,000	-2,846,000	-17,986,000	17,927,000	-2,771,000	487,000	2,579,000	3,432,000	-2,407,000	2,392,000	3,262,000	270,000	-5,000,000	-1,076,000	877,000	1,530,000	-5,788,000	-3,847,000	1,480,000	7,211,000	-6,481,000	2,662,000	2,334,000	3,481,000	-3,431,000	-1,318,000	3,834,000	-348,000	-1,634,000	133,000	902,000	3,217,000	-2,567,000	311,000	-265,000	-604,000	-1,724,000	-1,414,000	21,000	546,000	-849,000	-1,452,000	1,436,000	424,000	-2,123,000	98,000	-1,166,000	1,584,000				1,256,212	-1,912,147	713,413	-1,073,308	215,012	-290,470	-1,475,719	-500,371	-336,671
accrued employee costs	30,085,000	34,288,000	-65,566,000	28,143,000	28,693,000	29,118,000	-64,246,000	15,943,000	22,478,000	32,984,000	-57,315,000	17,329,000	22,238,000	25,992,000	-60,008,000	19,811,000	22,831,000	27,444,000	-23,611,000	12,189,000	11,643,000	13,549,000	-37,046,000	13,495,000	15,987,000	9,869,000	-22,436,000	8,952,000	13,031,000	6,944,000	-27,655,000	7,306,000	10,697,000	9,441,000	-21,053,000	9,116,000	6,470,000	9,285,000	-19,567,000																						5,676,000	4,214,000	-5,660,000
accounts payable, accrued expenses and other liabilities	6,529,000	-14,362,000	22,901,000	10,332,000	10,816,000
operating lease liabilities	-6,645,000	-6,410,000	-5,840,000	-5,309,000	-5,535,000	-5,029,000	-4,616,000	-4,559,000	-4,793,000	-5,376,000	-5,453,000	-5,396,000	-5,909,000	-5,917,000	-6,005,000	-6,020,000	-6,327,000	-6,459,000	-6,868,000	-6,809,000	-6,949,000	-6,255,000	-6,576,000	-5,385,000	-5,679,000
payment of contingent consideration				0	0	0	-11,000,000	0	0
net cash from operating activities	120,716,000			105,346,000	110,142,000			79,038,000	68,601,000			65,052,000	48,081,000			70,625,000	59,819,000			76,659,000	67,407,000			62,465,000	58,238,000			45,584,000	33,058,000			40,956,000	25,283,000			44,216,000	29,127,000			42,141,000	27,383,000	27,030,000	137,000	22,354,000	16,552,000	22,788,000	4,965,000	38,562,000	18,829,000	18,779,000	6,622,000	22,426,000	23,903,000	15,084,000	4,369,000	15,727,000	13,732,000			12,810,000	16,739,000	7,808,000	-851,000	19,436,000	9,658,000	7,841,000	-1,240,000	15,955,514	10,096,301	16,331,088	-8,009,900	12,044,727	10,258,167			8,973,514
capex	-17,168,000			-10,768,000	-13,243,000			-11,697,000	-14,993,000			-12,737,000	-7,045,000			0	-9,123,000			-7,610,000	-12,563,000			0	-10,021,000			-10,367,000	-10,774,000			0	-6,312,000			0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0			0
free cash flows	103,548,000			94,578,000	96,899,000			67,341,000	53,608,000			52,315,000	41,036,000			70,625,000	50,696,000			69,049,000	54,844,000			62,465,000	48,217,000			35,217,000	22,284,000			40,956,000	18,971,000			44,216,000	29,127,000			42,141,000	27,383,000	27,030,000	137,000	22,354,000	16,552,000	22,788,000	4,965,000	38,562,000	18,829,000	18,779,000	6,622,000	22,426,000	23,903,000	15,084,000	4,369,000	15,727,000	13,732,000			12,810,000	16,739,000	7,808,000	-851,000	19,436,000	9,658,000	7,841,000	-1,240,000	15,955,514	10,096,301	16,331,088	-8,009,900	12,044,727	10,258,167			8,973,514
cash flows from investing activities:
purchases of property and equipment	-14,361,000	-14,426,000	-12,940,000	-10,074,000	-12,859,000	-12,063,000	-11,266,000	-11,697,000	-14,993,000	-13,634,000	-12,479,000	-12,737,000	-7,045,000	-8,953,000	-16,101,000		-9,123,000	-7,223,000	-12,680,000	-7,610,000	-12,563,000	-9,777,000	-12,274,000
proceeds from sale of property and equipment	135,000	85,000	95,000	43,000	82,000	28,000	62,000	99,000	93,000	-18,000	565,000	69,000	43,000	91,000	63,000	475,000	298,000	398,000	129,000	292,000
investment in equity affiliate	-574,000	0	-600,000	0				0												0	0	0	-700,000
business acquisition				167,000								-550,000	-750,000	-1,205,000	-1,367,000													89,000	-231,423,000	-115,000	-380,000					-19,239,000				0	0	149,000	-44,419,000	-51,941,000				0	0	0	-1,183,000					190,000	-1,083,000				-9,000	-13,013,000	-29,122,000	-24,000				-206,845	-253,621	0	-1,695,655					-653,697
purchases of investments	-102,354,000	-54,750,000	-90,185,000	-63,457,000	-65,701,000	-94,922,000	-64,932,000	-70,348,000	-51,198,000	-62,328,000	-51,495,000	-48,294,000	-68,231,000	-59,278,000	-36,804,000
proceeds from redemption of investments	70,832,000	55,072,000	81,362,000	48,697,000	52,318,000	59,019,000	80,825,000	58,511,000	66,347,000	44,428,000	106,750,000	40,148,000	41,788,000	33,052,000	49,515,000		19,152,000	58,674,000	5,357,000	22,436,000	30,874,000	0	72,844,000	47,825,000	37,474,000	70,308,000	21,361,000	48,672,000	18,725,000	30,453,000	30,358,000	187,201,000	14,763,000
net cash from investing activities	-46,322,000						4,689,000					-21,364,000			-4,694,000									-30,045,000	-22,293,000	38,153,000	-37,200,000	-37,083,000			-3,012,000	-51,594,000	-20,748,000	-33,322,000	-117,072,000	71,575,000	-20,274,000	-16,188,000	-89,780,000	72,379,000	-21,407,000	-68,332,000	-56,180,000	-57,641,000	-12,576,000	-6,361,000	-11,684,000	-3,941,000	-2,245,000	-3,505,000	-7,844,000	-38,838,000	-3,826,000	-3,725,000	-8,445,000	-5,013,000	-10,570,000	-82,939,000	-7,230,000	-5,713,000	-4,641,000	-17,954,000	-32,664,000	-5,425,000	-6,722,000	-1,619,000	-3,565,000	-2,096,646	-1,712,285	-3,632,097	-8,549,260	-1,882,703	-2,213,291	-1,829,233	-3,039,802	-7,275,948
cash flows from financing activities:
principal payments of finance lease liabilities	-118,000	-131,000	-116,000	-104,000	-90,000	-72,000	-60,000	-49,000	-40,000	-37,000	-43,000	-34,000	-33,000	-36,000	-39,000	-44,000	-50,000	-50,000	-57,000	-69,000	-56,000	-57,000	-67,000
proceeds from borrowings	125,000,000	0	50,000,000	0	110,000,000	0	180,000,000	10,000,000	0	20,000,000	50,000,000	0	0	0	35,000,000	75,000,000	200,000,000	0	25,000,000	0	0	0	110,000,000	0	0	0	46,000,000	1,614,000	233,000,000	0	12,000,000									0	0
repayments of borrowings	-30,250,000	-47,250,000	-31,250,000	-56,250,000	-100,000,000	-10,000,000	-35,000,000	-20,000,000	-10,000,000	0	-100,000,000	-20,000,000	-15,000,000			-31,000	-230,000,000	-74,000,000	-25,000,000	-474,000	-10,183,000	-100,009,000	-10,201,000	-10,484,000	-8,173,000	-69,018,000	-10,572,000	-150,126,000	-18,000	-29,000	-5,036,000					0	0	-20,000,000	-5,000,000	0	0
acquisition of treasury stock	-159,235,000	-41,679,000	-17,994,000	-12,046,000	-35,233,000	-8,420,000	-152,227,000	-31,305,000	-29,904,000	-28,275,000	-42,363,000	-930,000	-11,521,000	-28,806,000	-31,385,000	-32,737,000	-28,196,000	-28,409,000	-29,015,000	-41,048,000	-24,906,000	0	-13,995,000	-5,480,000	-8,346,000	-12,130,000	-15,408,000	-10,316,000	-9,657,000	-9,632,000	-13,504,000	-11,118,000	-9,004,000	-11,419,000	-11,913,000	-3,034,000	-5,465,000	-2,849,000	-6,855,000	-1,180,000	-7,910,000	-4,708,000	-397,000	0	-2,863,000	0	-459,000	-21,229,000	0	0	-389,000	0	0	-149,000	-182,000	0	19,000			0	0			0	0	-28,000	-45,000	-349,003	-208,933	-15,889	-12,939
proceeds from issuance of common stock	1,226,000	1,103,000	2,765,000	1,499,000	1,050,000	960,000	1,514,000
payment of debt issuance costs				-29,000																				0	0	-20,000	-97,000													0	0	-24,000	-50,000													0	0
net cash from financing activities	-63,377,000			-66,930,000	-24,866,000	-17,532,000	-9,773,000	-40,478,000	-39,139,000			-19,904,000	-26,554,000			42,188,000	-57,710,000				-35,060,000	-100,027,000	86,658,000							-9,702,000	-6,151,000		-6,546,000	-9,883,000	-11,765,000						-7,315,000	-14,384,000	31,213,000		-949,000	864,000	926,000		1,698,000	725,000	555,000	2,627,000	1,201,000	3,802,000	2,275,000	865,000	-7,173,000	30,664,000	510,000		792,000				-11,000				-141,473
effect of exchange rate changes	-1,709,000	4,646,000	2,700,000				-1,212,000
net increase in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash at the beginning of the period	0	0	171,398,000	0	4,386,000	-4,386,000	145,401,000	0	0	0	125,621,000	0	0	0	143,810,000		0	0	225,519,000	0	0	0	127,044,000
cash, cash equivalents and restricted cash at the end of the period	9,308,000	12,047,000	158,478,000	8,134,000	41,610,000	4,422,000	117,232,000	17,442,000	27,299,000	5,695,000	94,965,000	27,350,000	-16,929,000	131,000	115,069,000		-33,843,000	-27,178,000	184,714,000	9,507,000	45,237,000	-62,759,000	233,534,000
supplemental disclosure of cash flow information:
cash paid during the period for:
interest	4,257,000	4,426,000	3,790,000	5,258,000	5,406,000	5,969,000	2,971,000	3,315,000	3,666,000	3,589,000	3,325,000	3,207,000	2,288,000	1,417,000	1,277,000	756,000	2,234,000	2,989,000	610,000
income taxes	12,154,000	33,370,000	9,595,000	28,345,000	27,908,000	39,039,000	11,122,000
supplemental disclosure of non-cash investing and financing activities:
additions to property and equipment not yet paid	-2,807,000	2,421,000	3,765,000	-694,000	-384,000	-241,000	3,381,000
assets acquired under finance lease	100,000	336,000	297,000	353,000	391,000	294,000	287,000	176,000	194,000	-8,000	99,000	94,000	100,000	68,000	50,000	-8,000	29,000	40,000	10,000
net decrease in cash, cash equivalents and restricted cash		12,047,000	-12,920,000			8,808,000	-28,169,000			5,695,000	-30,656,000		-16,929,000	131,000	-28,741,000											-3,180,000	-9,504,000
adjustments to reconcile net income to net cash provided by/(used for) operating activities:
other current and non-current asset			-22,945,000
net cash (used for)/provided by operating activities			3,243,000				-21,873,000								-26,870,000								-13,555,000								-8,005,000
net cash (used for)/provided by investing activities			-22,268,000		-51,226,000
net cash (used for)/provided by financing activities			3,405,000								-91,304,000								-28,997,000																			-20,781,000	-9,968,000
fair value mark-to-market on investments
unrealized foreign currency exchange gain								-501,000					-6,533,000	-7,115,000	-3,165,000
effect of exchange rate changes on cash, cash equivalents and restricted cash				-5,658,000	3,174,000			2,317,000	-1,812,000	242,000	1,282,000	3,566,000	-4,261,000	-4,612,000	-753,000	56,000	-2,766,000	-1,253,000	-984,000	3,362,000	2,893,000	-220,000	-2,653,000	716,000	-1,521,000	215,000	-455,000	140,000	-426,000	-1,938,000	-644,000
net increase/(decrease) in cash, cash equivalents and restricted cash								17,442,000														-62,759,000	106,490,000
change in operating assets and liabilities, net of effects of acquisitions:
(reversal)/allowance for expected credit losses							-240,000
fair value changes in contingent consideration							-589,000	-600,000				7,250,000	0
other current assets							-11,394,000	-9,094,000	3,975,000	1,659,000	-6,046,000	-10,262,000
other assets							-3,575,000	3,959,000	-6,020,000	-8,600,000	-4,172,000	-2,295,000	-1,844,000	-3,660,000	-2,924,000	-2,258,000	896,000	321,000	1,268,000	3,409,000	50,000	2,121,000	925,000	-897,000	-1,433,000	-262,000	388,000	-816,000	-1,697,000	-2,498,000	-1,789,000	-3,465,000	1,277,000	-1,605,000	1,569,000	5,430,000	-243,000	-581,000	148,000	-648,000	-355,000	-148,000	-257,000	609,000	-749,000	-1,136,000	-570,000	-544,000	1,162,000	-569,000	636,000	-2,005,000	269,000	2,010,000	-422,000	-4,690,000	5,058,000	-480,000	411,000	-137,000	-3,488,000	1,256,000	-818,000					-63,858	18,658	3,762	-3,082,979	-62,811	357,116	-1,951,110	-3,901,928	2,880,162
accounts payable							-1,936,000	1,867,000	172,000	-351,000	-4,445,000	4,312,000	-820,000	-299,000	-808,000	1,719,000	125,000	-4,360,000	1,902,000	733,000	-2,433,000	543,000	1,400,000	1,981,000	267,000	-955,000	-1,159,000	1,054,000	-71,000	383,000	-1,726,000	1,335,000	-4,924,000	3,110,000	2,185,000	-110,000	-1,091,000	1,157,000	-2,584,000	1,646,000	-1,138,000	520,000	-984,000	644,000	-1,209,000	543,000	-124,000	788,000	120,000	-916,000	-367,000	3,229,000	479,000	-1,258,000	569,000	-570,000	-455,000	1,244,000	-1,059,000	382,000	-751,000	385,000	-161,000	739,000	228,000	177,000	67,000	123,539	924,157	-1,717,063	-933,559	2,297,343	-883,550	531,025	-568,915	418,128
accrued expenses and other liabilities							10,307,000	5,784,000	5,041,000	-27,673,000	26,931,000	790,000	2,495,000	-4,457,000	15,647,000	-320,000	-9,036,000	3,834,000	8,456,000	-9,786,000	4,073,000	-5,154,000	972,000	1,981,000	6,960,000	-637,000	5,837,000	-648,000	-3,189,000	-564,000	3,317,000	6,636,000	6,341,000	-6,880,000	806,000	3,392,000	1,275,000	266,000	4,147,000	-726,000	-915,000	-2,561,000	-497,000	5,577,000	6,808,000	-2,974,000	-985,000	10,724,000	-4,735,000	1,811,000	1,071,000	-268,000	-1,565,000	235,000	883,000	602,000	4,477,000	9,578,000	-6,137,000	8,926,000	-920,000	-193,000	1,269,000					4,354,325	2,929,451	5,175,386	-5,922,955	-353,708	3,783,329	4,127,679	-3,759,990	251,712
fair value mark-to-market of short-term investments
allowance/(reversal) for expected credit losses
loss on settlement of convertible notes																0
amortization of non-cash interest expense related to convertible notes
settlement of portion of convertible notes through issuance of treasury stock																0
amortization of operating lease right-of-use assets									4,839,000	5,449,000	4,883,000	4,418,000	5,360,000	5,962,000	6,043,000	6,314,000	6,380,000	6,871,000	6,761,000	6,662,000	6,781,000	6,850,000	6,853,000	6,791,000	6,843,000
unrealized loss/(gain) on investments											8,186,000
allowance for expected credit losses									1,965,000	137,000	342,000				34,000			-438,000	48,000	-56,000	-36,000	194,000	195,000
net cash provided by/(used for) investing activities									-351,000	-31,552,000	43,341,000												36,040,000
proceeds from espp contribution and exercise of stock options
income taxes, net of refunds									23,444,000	46,774,000	6,525,000	20,400,000	20,891,000	8,897,000	5,404,000	18,738,000	12,377,000	16,295,000	2,415,000
unrealized (gain)/loss on investments												-734,000
proceeds from espp contribution										2,698,000	1,102,000
proceeds from exercise of stock options																0	536,000	99,000	75,000	456,000	85,000	39,000	921,000	649,000	0	316,000	22,000	313,000	653,000	0	431,000	4,286,000	2,497,000	1,587,000	191,000	273,000	2,031,000	2,185,000	2,010,000	213,000	796,000	483,000	1,883,000	1,489,000	2,157,000	1,140,000	1,673,000	865,000	2,168,000	1,078,000	1,378,000	734,000	1,589,000	4,377,000	2,903,000	174,000	1,783,000	2,983,000	595,000	1,437,000	796,000	530,000	261,000	786,000	14,000			234,681	71,087	283,978	30,320	554,192			10,367	14,165
unrealized foreign currency exchange loss/(gain)											2,814,000
net cash provided by/(used for) operating activities											16,025,000																8,343,000								7,073,000																								7,752,000																-8,314,796
deferred income tax (benefit)/expense																			-2,695,000												3,433,000	6,148,000	-2,299,000
net (decrease)/increase in cash, cash equivalents and restricted cash																20,117,000	-33,843,000	-27,178,000	-40,805,000
allowance / (reversal) of expected credit losses													7,000
amortization of non-cash interest expense related to convertible senior notes																		691,000	673,000	673,000	654,000	654,000	635,000	636,000	618,000	618,000	600,000
unrealized (gain)/loss on short term investments
(gain)/income from equity-method investment														-143,000	-114,000
prepaid expenses and other current assets														3,977,000	-1,116,000	-4,212,000	2,844,000	210,000	-21,000	-6,631,000	2,589,000	2,158,000	-3,249,000	463,000	2,785,000	-2,624,000	591,000	-1,165,000	-914,000	-266,000	-2,164,000	-4,976,000	-1,967,000	8,446,000	-1,285,000	-4,834,000	590,000	2,464,000	-3,641,000	-4,089,000	2,120,000	1,656,000	-2,799,000	-2,039,000	117,000	2,179,000	-4,187,000	544,000	-1,573,000	-463,000	-1,926,000	2,924,000	-842,000	-1,583,000	-2,292,000	1,664,000	-7,389,000	1,609,000	-544,000	-2,268,000	490,000	-1,314,000	926,000	-1,808,000	869,000	1,583,000	-698,000	-2,530,368	244,252	-3,668,619	3,158,822	-960,238	1,023,845	1,101,706	932,684	-3,334,888
advance income tax														2,499,000	6,185,000	-6,377,000	-5,724,000	-9,018,000	9,057,000	-6,305,000	2,555,000	5,555,000	-1,109,000	982,000	4,867,000	3,444,000	-2,099,000	-9,919,000	3,377,000	6,301,000	-13,906,000	13,644,000	-1,490,000	354,000	-1,471,000	5,185,000	-1,569,000	1,250,000	-4,429,000	3,114,000	2,126,000	3,081,000	544,000	-2,337,000	759,000	-4,441,000	-1,822,000	-368,000	1,985,000	630,000	-141,000	-4,088,000	-413,000	2,371,000	817,000
adjustments to reconcile net income to net cash (used for)/provided by operating activities:
unrealized gain on short term investments															-384,000					-2,367,000	-1,965,000	-3,109,000	267,000	-2,673,000	-3,081,000	-1,177,000	-3,185,000	-2,273,000	-1,483,000	-1,098,000	-2,842,000		-2,191,000				-1,971,000	-1,459,000	-1,525,000		-1,419,000
net cash provided by/(used for) financing activities															3,576,000												19,808,000	-10,324,000																																			225,000				-72,000				20,983	745,065	282,044	1,013,733	-80,539
unrealized loss/(gain) on short term investments
reversal/(allowance) for expected credit losses
impairment charges																								460,000	0	1,940,000	1,227,000
purchase of property and equipment																									-10,021,000	-11,409,000	-10,878,000	-10,367,000	-10,774,000	-6,616,000	-12,680,000
proceeds from redemptions of investments
purchase of non-controlling interest																								0	0
cash, cash equivalents and restricted cash at the beginning of the year
cash, cash equivalents and restricted cash at the end of the year
cash paid during the year for:
unrealized (gain) / loss on short term investments																			-1,103,000
unrealized foreign exchange gain																	-1,165,000																			-854,000	-105,000																								622,000
allowance / (reversal) for expected credit losses
income from equity-method investment																		-8,000	36,000	34,000	72,000	66,000	55,000	71,000	69,000	62,000	67,000	71,000	62,000	58,000	56,000
purchase of investments																	-43,513,000	-14,152,000	-18,835,000	-44,497,000	-8,938,000	-25,197,000	-23,830,000	-70,040,000	-49,746,000	-20,505,000	-47,683,000	-75,477,000	-17,294,000	-20,353,000	-20,310,000	-204,824,000	-28,475,000
unrealized loss / (gain) on short term investments
adjustments to reconcile net income to net cash from / (used for) operating activities:
unrealized foreign exchange (gain)																			-1,139,000
net cash from /(used for) operating activities																			15,205,000
net cash (used for) /provided by investing activities																			-26,029,000
unrealized foreign exchange (gain)/loss																				839,000	2,879,000	1,796,000	-5,112,000					5,755,000	-6,593,000	-4,463,000	-3,319,000								-1,061,000																	-3,543,000							599,000	883,000	17,000	-625,000	-373,000		3,447,564
proceeds from convertible notes
restricted common stock issued for business acquisition																												0
deferred income tax expense/
deferred income tax expense																							3,539,000				1,049,000
allowance for doubtful accounts receivable																								181,000	152,000	-17,000	298,000
cash paid for interest																																																																				8,587	10,492	7,761	25,182	12,208	9,898	7,830	12,440	3,059,587
cash paid for taxes, net of refund
depreciation and amortization																									13,101,000	12,808,000	13,724,000	13,374,000	14,066,000	10,624,000	10,655,000	10,213,000	9,708,000	9,637,000	9,426,000	9,580,000	8,597,000	8,270,000	8,133,000	8,294,000	8,057,000	8,061,000	7,053,000	7,979,000	7,014,000	6,679,000	6,356,000	6,074,000	5,969,000	6,362,000	6,512,000	6,891,000	6,333,000	6,040,000	6,359,000	6,589,000	6,443,000	5,110,000	4,852,000	4,687,000	4,218,000	3,857,000	3,073,000	3,268,000	2,918,000	2,789,000	2,430,000	2,854,679	2,465,057	3,133,158	2,703,039	2,726,350	2,560,476	2,764,035	2,440,902	2,684,786
unrealized foreign exchange loss/(gain)																									-1,948,000	1,840,000	127,000
principal payments on finance lease liabilities
net cash (used for) / provided by financing activities
cash, cash equivalents and restricted cash at beginning of period																									0	0	104,131,000
cash, cash equivalents and restricted cash at end of period																									17,838,000	-3,180,000	94,627,000
non-cash investing and financing transaction
principal payments on finance lease obligations																										-70,000	-137,000
adjustments to reconcile net income to net cash provided/(used for) by operating activities:
excess tax benefit from stock-based compensation																																																																								1,384,722	-377,000	-283,722	28,861
change in fair value of earn-out consideration																																				0	0	-3,810,000	-250,000
principal payments on capital lease obligations																												-47,000	-22,000	-41,000	-42,000	-41,000	-39,000	-51,000	-43,000	-56,000	-52,000	-117,000	-123,000	-161,000	-201,000	-135,000	-223,000	-160,000	-243,000	-276,000	-288,000	-281,000	-443,000	-353,000	-434,000	-380,000	-388,000	-426,000	-446,000					3,000	-4,000	-51,000	-36,000	-34,000	-25,000	-28,000	-27,000	-70,560	-31,319	-34,434	3,602	69,873	-59,685	-43,721	-119,767	-112,442
cash, cash equivalents and restricted cash at beginning of year
cash, cash equivalents and restricted cash at end of year
assets acquired under capital lease																																																																				16,984	81,977	92,271	31,492	-126,741	187,498	12,008	33,259	88,941
allowances for doubtful accounts receivable																													-30,000	22,000	-612,000
net increase/(decrease) in cash, cash equivalents, and restricted cash
cash, cash equivalents, and restricted cash at beginning of period																													0	0	94,277,000
cash, cash equivalents, and restricted cash at end of period																													15,822,000	13,527,000	76,465,000
net decrease in cash, cash equivalents, and restricted cash																														13,527,000	-17,812,000
change in operating assets and liabilities
restricted cash																																-1,776,000	-71,000	778,000	1,050,000	-1,673,000	-778,000	1,233,000	-919,000	526,000	-116,000	280,000	-1,477,000	-379,000	-77,000	211,000	-502,000	6,000	-112,000	283,000	-239,000	90,000	3,000	-233,000	108,000	-535,000	62,000	93,000	-118,000	193,000	3,707,000	113,000	-3,582,000	1,200,000	-1,986,000			-10,968	-1,526	512,593	-551,140	204,937	115,908	-74,672	646,613	-112,227
business acquisitions
proceeds from non-controlling interest
effect of exchange rate changes on cash and cash equivalents																																2,049,000	262,000	1,091,000	309,000	-2,519,000	-106,000	-3,048,000	640,000	-359,000	-2,656,000	-982,000	-350,000	-1,747,000	-2,536,000	-46,000	1,420,000	-257,000	-458,000	-3,737,000	-63,000	-1,757,000	2,781,000	-2,913,000	1,680,000	-2,062,000	-2,468,000	63,000	329,000	-70,000	880,000	-642,000	315,000	264,000	294,000	1,351,000	-702,000	-3,084,074	-4,155,934	-940,953	3,283	286,702	84,937	55,374	-3,786	619,592
net increase/(decrease) in cash and cash equivalents																																																				-15,542,000	24,059,000						1,361,000	8,574,000	13,770,000	-10,402,000	-32,975,000		3,219,000								8,411,857	8,676,906	-11,438,923
cash and cash equivalents, beginning of year																																							205,323,000
cash and cash equivalents, end of year																																							95,774,000
unrealized foreign exchange loss/																																	-1,197,000	-582,000	2,225,000
allowances for doubtful accounts
purchase of property, plant and equipment																																	-6,312,000	-10,333,000	-10,114,000
net decrease in cash and cash equivalents																																	-1,749,000	-2,286,000	-121,455,000		5,261,000	-2,661,000	-109,549,000				-25,180,000				-4,373,000				-730,000						-6,479,000										-5,579,000			11,991,693	-16,534,894
cash and cash equivalents, beginning of period																																	0	0	213,155,000		0				0	0	176,499,000	0	0	0	148,065,000	0	0	0	103,037,000	0	0	0	82,393,000	0	0	0	111,182,000	0	0	0	132,215,000		0	0	112,174,000
cash and cash equivalents, end of period																																	-1,749,000	-2,286,000	91,700,000		5,261,000				-3,995,000	-56,668,000	151,319,000	15,071,000	491,000	17,245,000	143,692,000	15,672,000	17,824,000	12,262,000	102,307,000	-15,542,000	24,059,000	12,248,000	82,272,000	9,517,000	-6,479,000	-33,188,000	112,543,000	8,574,000	13,770,000	-10,402,000	99,240,000
deferred income taxes																																			-4,256,000	-7,808,000	817,000	-39,000	3,646,000	-1,358,000	324,000	468,000	2,804,000	-312,000	-2,321,000	846,000	1,863,000	655,000	-544,000	1,182,000	1,191,000	2,669,000	3,329,000	-2,225,000	954,000	955,000	-1,432,000	325,000	-1,553,000	208,000	-139,000	-1,444,000	-1,000,000	-1,651,000	-5,627,000	-364,000	-758,000	-868,581	1,048,618	-610,936	-196,153	-2,635,553	-2,602	-155,178	-587,060	-1,066,093
purchase of short-term investments																																			-129,837,000	-26,762,000	-23,434,000	-30,948,000	-101,327,000	-19,888,000	-37,299,000	-65,868,000	-5,995,000	-1,533,000	-6,193,000	-403,000	-1,005,000	-235,000	-1,526,000	-115,000	-51,000	2,327,000	-6,386,000	-1,923,000	-1,369,000	-923,000	-6,007,000	-1,816,000	-72,000	-2,089,000	0			-3,171,000							-4,474
proceeds from redemption of short-term investments																																			22,879,000	123,091,000	18,050,000	21,175,000	20,004,000	96,725,000	22,639,000	2,922,000	3,079,000	-251,000				475,000	735,000			-1,869,000	6,369,000	2,098,000	2,223,000	2,813,000	291,000			1,406,000	207,000				0
net increase in cash and cash equivalents																																												15,071,000	491,000				17,824,000																											59,737,229
purchase of fixed assets																																					-5,463,000	-6,415,000	-8,457,000	-4,458,000	-6,747,000	-5,535,000	-8,845,000	-3,916,000	-7,125,000	-5,958,000	-10,679,000	-4,181,000	-1,454,000	-3,671,000	-6,610,000	-1,796,000	-3,809,000	-3,900,000	-9,299,000	-7,093,000	-3,771,000	-1,446,000	-7,158,000	-5,030,000	-4,839,000	-4,606,000	-5,385,000	-2,230,000	-2,401,000	-1,772,000	-5,013,000	-2,017,210	-2,329,698	-3,636,571	-6,849,131	-1,630,142	-2,213,291	-1,829,233	-3,039,802	-6,622,151
net cash (used)/provided by financing activities
net cash (used for) / provided by operating activities																																							-10,441,000
write-off of accounts receivable
payment for purchase of non-controlling interest																																																0
accrued employee cost																																									8,635,000	8,223,000	-16,398,000		2,342,000	6,553,000	-11,493,000		3,256,000	4,593,000	-11,192,000		5,834,000	5,947,000	-13,229,000		2,759,000								2,535,000	2,426,000	-7,545,000
net (decrease)/increase in cash and cash equivalents																																																							-121,000
unrealized foreign exchange (gain) / loss
net (decrease) / increase in cash and cash equivalents
unrealized foreign exchange loss																																											284,000				1,895,000				958,000				1,711,000				297,000
proceeds from long-term borrowings																																											25,000,000
proceeds from short-term borrowings																																											5,000,000													0	0
loss on sale of business unit
amortization of deferred financing costs																																													0	15,000	38,000																													67,500
gain on sale of fixed assets																																													-27,000	-45,000	-16,000
non-controlling interest																																																0	0	1,000	1,000	1,000				1,000
unrealized foreign exchange gain/
amortization of deferred financing cost																																																			38,000	37,000
non-employee stock options																																																				0	0	0	32,000	12,000	8,000			26,000	29,000
gain on bargain purchase
proceeds from sale of common stock, net of issuance costs
repayments of short-term borrowings																																																								0	-30,035,000
amortization of debt issuance cost																																																	38,000
loss on sale of a business unit
proceeds from issuance of common stock from public offering
direct costs incurred in relation to public offering
amortization of debt issuance costs																																																							38,000
change in operating assets and liabilities :
income from discontinued operations, net of taxes																																																																				31,228
excess tax (benefit)/expense from stock-based compensation
proceeds from sale of discontinued operations																																																																0	0	0	1,448,000	127,409
proceeds from issuance of stock to minority shareholders
excess tax benefit/(expense) from stock-based compensation
advance income-tax																																																									1,120,000
principal payments of capital lease obligations																																																									-513,000	-250,000	-51,000
proceeds from issuance of common stock in public offering
payment on purchase of treasury stock																																																											-34,000
loss/ (income) from discontinued operations, net of taxes
excess tax expense/(benefit) from stock-based compensation
net cash from operating activities—continuing operations
net cash from operating activities—discontinued operations
net cash from investing activities-continuing operations
net cash from investing activities-discontinuing operations
net cash provided by/ (used for) financing activities
share-based compensation expense																																																													2,121,000	2,403,000	1,828,000	1,704,000	1,876,000
noncontrolling interest																																																													0	0	7,000
cash flows from operating activities
cash flows from investing activities
proceeds from redemption of short-term investment																																																															1,843,000
cash flows from financing activities
(income)/ income from discontinued operations, net of taxes
net cash from operating activities–continuing operations
net cash from operating activities–discontinued operations
net cash from investing activities–continuing operations
net cash from investing activities–discontinued operations
excess tax benefit/(deficiency) from stock-based compensation
less: cash and cash equivalents of discontinued operations, end of year
cash and cash equivalents of continuing operations, end of year
issuance of stock on acquisition of inductis
(income)/income from discontinued operations, net of taxes																																																																	0
non employee stock options																																																																	24,000	15,000	71,000		63,561	56,075	73,755	165,665	181,834	81,540	116,252	315,420
accrued expenses and other current liabilities																																																																	1,522,000	406,000	-2,249,000
other assets and liabilities																																																																	-428,000	298,000	799,000
net cash from operating activities - continuing operations																																																																	9,658,000	7,841,000	-1,240,000
net cash from operating activities - discontinued operations
net cash from investing activities - continuing operations																																																																	-6,722,000	-1,619,000	-3,565,000
net cash from investing activities - discontinued operations
less cash and equivalents of discontinued operations, end of period
cash and equivalents of continuing operations, end of period																																																																	3,219,000	7,696,000	106,595,000
income/(loss) from discontinued operations, net of taxes																																																																			-139,000
amortization of deferred stock compensation and other non-cash compensation																																																																			1,539,000	852,107	1,551,255	1,886,588	988,328	944,670	1,443,006	1,090,787	828,209	694,153
interest on senior long-term debt
foreign exchange																																																																								121,854	-3,207	-950,300	-100,073
repayment of senior long-term debt
repayment on redemption of preferred stock
repayment of bank borrowings and other long term debt
net cash provided by/(used for) financing activities–continuing operations
net cash from financing activities–discontinued operations
cash paid for taxes																																																																				839,361	383,619	751,976	2,223,000	639,078	866,455	3,252,193	2,486,756	2,016,402
supplemental disclosure of non-cash information:
fair value of shares issuable for non-cash consideration
cash and cash equivalents at the beginning of the year																																																																					0	0	102,209,734	0	0	0	85,366,103	0
less cash and equivalents of discontinued operations at end of period
cash and equivalents at end of period
fair value of shares issued for non-cash consideration
cash and cash equivalents at the end of the period																																																																						11,991,693	85,674,840	11,193,791	8,411,857	8,676,906	73,927,180	59,737,229
foreign exchange gain																																																																							-851,376
excess tax benefit from stock–based compensation
interest expense–redeemable preferred stock
interest on senior long term debt																																																																												18,317
repayment of bank borrowings																																																																												1,400,000
repayment of long term debt																																																																												-1,400,000
outflow from treasury stock transactions																																																																												0
supplemental disclosure of cash flow information
supplemental disclosure of non-cash information
fair value of the shares issued for non cash consideration																																																																									0	0	5,449,042	0
proceeds from exercise of stock options and tax recoveries
excess tax benefit from stock—based compensation																																																																											-28,861
interest expense—redeemable preferred stock
purchase of common stock at cost
fair value of shares issuable for non cash consideration
foreign exchange loss

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.